Embolic Prevention Systems Market

Embolic Prevention Systems Market Overview

The global sales of embolic prevention systems are slated to grow at a CAGR of around 8.5% between 2022 and 2032, generating substantial revenues by the end of the forecast period. Growth in the market is driven by the rising prevalence of cardiovascular diseases and growing focus towards preventing embolic strokes.

Report Attribute	Details
Embolic Prevention Systems Market Projected Growth Rate (2022-2032)	8.5% CAGR

Over the last few there has been a rapid upsurge in the cases of embolic events or embolic strokes across the world due to various factors. Embolic strokes usually occur when a clot formed in the heart or any other place travels to the brain through bloodstream and blocks a blood vessel there. Embolic strokes or events can be life threatening and require immediate emergency medical care. This has prompted medical professionals to use embolic prevention systems.

Embolic Prevention Systems are innovative medical devices used to prevent or reduce debris from reaching distal sensitive places, thereby eliminating the potential of developing averse clinical events like embolic strokes. These systems are used during percutaneous cardiac procedures to reduce the number of complications due to debris being released into the bloodstream and causing blockage in smaller vessels.

Embolic prevention systems have become highly sought-after medical devices used in saphenous vein graft interventions and during carotid artery stenting procedures.

Rising in the number of cardiac interventions across the world is anticipated to create sales prospects for embolic prevention systems during the forecast period.

Various types of embolic prevention systems such as distal occlusion devices, proximal occlusion devices, and distal filters are being increasingly used by medical professionals to remove the debris during medical interventions.

Which are the Prominent Growth Drivers of Embolic Prevention Systems Market?

The swift growth of embolic prevention systems market is attributable to the increasing prevalence of cardiovascular and neurovascular diseases across the world, growing popularity of embolic preventions systems for eliminating the risk of embolism, surge in the number of surgeries performed, and rising health awareness among people about the potential risks of embolic events.

Increasing incidence of cardiovascular diseases is emerging as a key factor in boosting the growth of embolic prevention systems market and the trend is likely to pertain during the forecast period. According to the World Health Organization (WHO), taking over 17.9 million lives each year, cardiovascular diseases remain the leading cause of death globally.

In order to treat these cardiovascular diseases and reduce this mortality rate, various surgical and non-surgical interventions are being performed by medical professionals, which eventually creates demand for embolic protection systems. These systems help surgeons to capture and remove debris that may be released during cardiac procedures.

Moreover, various initiatives and awareness programs launched by the government and non-government organizations to educate people about cardiovascular and neurovascular diseases along with their possible treatments will further expand the size of embolic prevention systems market in future

In addition to this, advancement in embolic prevention systems coupled with increasing strategic collaborations among major players is expected to further accelerate the growth of the market in future.

What are the Challenges Faced by the Embolic Prevention Systems Industry?

Despite various advantages of embolic prevention systems, there are certain factors that are restraining market growth. Some of these factors are the high procedural time, presence of alternatives like drugs, and lack of adoption across some developing and underdeveloped countries.

Will North America Continue to Lead the Embolic Prevention Systems Market?

North America remains at the epicenter of embolic prevention systems market growth owing to the heavy presence of leading market players, adoption of new technologies, surge in minimally invasive procedures, and increasing prevalence of cardiovascular diseases.

Most of the embolic prevention system sales remain concentrated in the United States due to increase in cardiac interventions like transcatheter aortic valve replacement (TAVR), expansion of healthcare industry, and rising medical tourism. According to an article published in the National Library of Medicine, over 80 000 TAVR procedures have been performed in the United States and the number is growing rapidly every year. This will continue to fuel the adoption of embolic prevention systems across the region,

Moreover, ongoing technological advancements in healthcare sector coupled with rising consumer inclination towards minimally invasive procedures will further generate growth prospects within the embolic prevention systems market during the forecast period.

How is the Demand Outlook for Europe Market?

According to Future Market Insights, Europe was the second largest market for embolic prevention systems in 2021 and is slated to register healthy growth over the forecast period, owing to the highly developed medical sector, presence of favorable reimbursement policies, increasing patient pool and advancement in cardiac artery stenting.

Annually, thousands of cardiac procedures are being performed across countries like the United Kingdom and Germany for treating various cardiovascular diseases. This has generated a huge demand for solutions like embolic prevention systems and the trend is likely to continue in the future.

Market Competition

Some of the key participants present in the global embolic prevention systems market include InspireMD Inc., Medtronic Plc, Boston Scientific, W.L. Gore & Associates, and Cardinal Health, among others.

In an attempt to increase their sales and retain their industry share, these market players are continuously adopting various growth strategies such as mergers, acquisitions, new product launches, partnerships, and establishment of new facilities in attractive regions.

Scope of Report

Report Attribute	Details
Growth Rate	CAGR of 8.5% from 2022 to 2032
Base Year for Estimation	2021
Historical Data	2015-2020
Forecast Period	2022-2032
Quantitative Units	Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered	Type Material Type Application End User Region
Regions Covered	North America Latin America Western Europe Eastern Europe APEJ Japan Middle East and Africa
Key Countries Profiled	U.S Canada Brazil Argentina Germany U.K France Spain Italy Nordics BENELUX Australia & New Zealand China India ASEAN GCC South Africa
Key Companies Profiled	InspireMD Inc. Medtronic Plc Boston Scientific W.L. Gore & Associates Cardinal Health Others
Customization	Available Upon Request

Key Segments Profiled in the Embolic prevention systems Industry Survey

By Type:

• Distal Occlusion Devices
• Distal Filters
• Proximal Occlusion Devices

By Material Type:

• Nitinol
• Polyurethane

By Application:

• Cardiovascular Diseases
• Neurovascular Diseases
• Peripheral Diseases

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• APEJ
• Japan
• Middle East & Africa